CAR T Cell Therapy’s Potential for Pediatric Brain Tumors

por Thomas, Pauline, Galopin, Natacha, Bonérandi, Emma, Clémenceau, Béatrice, Fougeray, Sophie, Birklé, Stéphane
Publicado 2021

Metabolic stress promotes renal tubular inflammation by triggering the unfolded protein response

por Fougeray, S, Bouvier, N, Beaune, P, Legendre, C, Anglicheau, D, Thervet, E, Pallet, N
Publicado 2011

Malarial Pigment Hemozoin and the Innate Inflammatory Response

por Olivier, Martin, Van Den Ham, Kristin, Shio, Marina Tiemi, Kassa, Fikregabrail Aberra, Fougeray, Sophie
Publicado 2014

Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy

por Fleurence, Julien, Fougeray, Sophie, Bahri, Meriem, Cochonneau, Denis, Clémenceau, Béatrice, Paris, François, Heczey, Andras, Birklé, Stéphane
Publicado 2017

The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine

por Harshman, L C, Fougeray, R, Choueiri, T K, Schutz, F A, Salhi, Y, Rosenberg, J E, Bellmunt, J
Publicado 2013

Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 Diabetes

por Berrou, Jeannig, Fougeray, Sophie, Venot, Marion, Chardiny, Victor, Gautier, Jean-François, Dulphy, Nicolas, Toubert, Antoine, Peraldi, Marie-Noëlle
Publicado 2013

Correction: Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 Diabetes

por Berrou, Jeannig, Fougeray, Sophie, Venot, Marion, Chardiny, Victor, Gautier, Jean-François, Dulphy, Nicolas, Toubert, Antoine, Peraldi, Marie-Noëlle
Publicado 2014

QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer

por Tabernero, Josep, Van Cutsem, Eric, Ohtsu, Atsushi, Amellal, Nadia, Cadour, Stéphanie, Fougeray, Ronan, Haffemayer, Benjamin, Mayer, Robert J
Publicado 2017

Intérêt des patients suivis pour rhumatisme inflammatoire chronique pour des téléconsultations d’ETP

por Lefeuvre, L., Vinadelle, C., Thomann, C., Fougeray, V., Brin, F., Maout, V., Le Goff, B., Goupille, P., Griffoul, I.
Publicado 2021

Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside

por Fleurence, Julien, Cochonneau, Denis, Fougeray, Sophie, Oliver, Lisa, Geraldo, Fanny, Terme, Mickaël, Dorvillius, Mylène, Loussouarn, Delphine, Vallette, François, Paris, François, Birklé, Stéphane
Publicado 2016

Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis

por Yoshino, T., Van Cutsem, E., Li, J., Shen, L., Kim, T.W., Sriuranpong, V., Xuereb, L., Aubel, P., Fougeray, R., Cattan, V., Amellal, N., Ohtsu, A., Mayer, R.J.
Publicado 2022

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study

por Tabernero, J., Shitara, K., Zaanan, A., Doi, T., Lorenzen, S., Van Cutsem, E., Fornaro, L., Catenacci, D.V.T., Fougeray, R., Moreno, S.R., Azcue, P., Arkenau, H.-T., Alsina, M., Ilson, D.H.
Publicado 2021

Zac1 and the Imprinted Gene Network program juvenile NAFLD in response to maternal metabolic syndrome

por Baptissart, Marine, Bradish, Christine M., Jones, Brie S., Walsh, Evan, Tehrani, Jesse, Marrero‐Colon, Vicmarie, Mehta, Sanya, Jima, Dereje D., Oh, Seh Hoon, Diehl, Anna Mae, Fougeray, Tiffany, Guillou, Hervé, Cowley, Michael
Publicado 2022

Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis

por Zamora, Audrey, Alves, Melinda, Chollet, Charlotte, Therville, Nicole, Fougeray, Tiffany, Tatin, Florence, Franchet, Camille, Gomez-Brouchet, Anne, Vaysse, Charlotte, Martinez, Laurent O., Najib, Souad, Guillermet-Guibert, Julie, Lacazette, Eric, Prats, Anne-Catherine, Garmy-Susini, Barbara
Publicado 2019

Gene Expression Profiling Reveals that PXR Activation Inhibits Hepatic PPARα Activity and Decreases FGF21 Secretion in Male C57Bl6/J Mice

por Barretto, Sharon Ann, Lasserre, Frédéric, Fougerat, Anne, Smith, Lorraine, Fougeray, Tiffany, Lukowicz, Céline, Polizzi, Arnaud, Smati, Sarra, Régnier, Marion, Naylies, Claire, Bétoulières, Colette, Lippi, Yannick, Guillou, Hervé, Loiseau, Nicolas, Gamet-Payrastre, Laurence, Mselli-Lakhal, Laila, Ellero-Simatos, Sandrine
Publicado 2019

Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study

por Bordonaro, R., Calvo, A., Auriemma, A., Hollebecque, A., Rubovszky, G., Saunders, M.P., Pápai, Z., Prager, G., Stein, A., André, T., Argilés, G., Cubillo, A., Dahan, L., Edeline, J., Leger, C., Cattan, V., Fougeray, R., Amellal, N., Tabernero, J.
Publicado 2021

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

por Van Cutsem, E., Danielewicz, I., Saunders, M. P., Pfeiffer, P., Argilés, G., Borg, C., Glynne-Jones, R., Punt, C. J. A., Van de Wouw, A. J., Fedyanin, M., Stroyakovskiy, D., Kroening, H., Garcia-Alfonso, P., Wasan, H., Falcone, A., Fougeray, R., Egorov, A., Amellal, N., Moiseyenko, V.
Publicado 2022